414 related articles for article (PubMed ID: 35226309)
1. Immunotherapy in Small Cell Lung Cancer Treatment: a Promising Headway for Future Perspective.
Walia HK; Sharma P; Singh N; Sharma S
Curr Treat Options Oncol; 2022 Feb; 23(2):268-294. PubMed ID: 35226309
[TBL] [Abstract][Full Text] [Related]
2. The role of immunotherapy in small cell lung cancer.
Calles A; Aguado G; Sandoval C; Álvarez R
Clin Transl Oncol; 2019 Aug; 21(8):961-976. PubMed ID: 30637710
[TBL] [Abstract][Full Text] [Related]
3. Rationale for chemotherapy, immunotherapy, and checkpoint blockade in SCLC: beyond traditional treatment approaches.
Spigel DR; Socinski MA
J Thorac Oncol; 2013 May; 8(5):587-98. PubMed ID: 23546044
[TBL] [Abstract][Full Text] [Related]
4. The Future of Immunotherapy in the Treatment of Small Cell Lung Cancer.
Horn L; Reck M; Spigel DR
Oncologist; 2016 Aug; 21(8):910-21. PubMed ID: 27354668
[TBL] [Abstract][Full Text] [Related]
5. PD-1 checkpoint blockade alone or combined PD-1 and CTLA-4 blockade as immunotherapy for lung cancer?
Tanvetyanon T; Gray JE; Antonia SJ
Expert Opin Biol Ther; 2017 Mar; 17(3):305-312. PubMed ID: 28064556
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy for small cell lung cancer: mechanisms of resistance.
Hamilton G; Rath B
Expert Opin Biol Ther; 2019 May; 19(5):423-432. PubMed ID: 30855195
[TBL] [Abstract][Full Text] [Related]
7. [Clinical Development of Immune Checkpoint Inhibitors in Patients with Small Cell Lung Cancer].
Zhang S; Liu J; Cheng Y
Zhongguo Fei Ai Za Zhi; 2017 Sep; 20(9):623-628. PubMed ID: 28935016
[TBL] [Abstract][Full Text] [Related]
8. Current state of the art and future perspectives with immunotherapy in the management of small cell lung cancer.
Rijavec E; Genova C; Biello F; Rossi G; Indini A; Grossi F
Expert Rev Respir Med; 2021 Nov; 15(11):1427-1435. PubMed ID: 34590937
[TBL] [Abstract][Full Text] [Related]
9. Immune checkpoint blockade in small cell lung cancer.
Tay RY; Heigener D; Reck M; Califano R
Lung Cancer; 2019 Nov; 137():31-37. PubMed ID: 31525648
[TBL] [Abstract][Full Text] [Related]
10. The next generation of immunotherapy: keeping lung cancer in check.
Somasundaram A; Burns TF
J Hematol Oncol; 2017 Apr; 10(1):87. PubMed ID: 28434399
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy for small-cell lung cancer: emerging evidence.
Reck M; Heigener D; Reinmuth N
Future Oncol; 2016 Apr; 12(7):931-43. PubMed ID: 26882955
[TBL] [Abstract][Full Text] [Related]
12. Systemic Therapy of Extensive Stage Small Cell Lung Cancer in the Era of Immunotherapy.
Ragavan M; Das M
Curr Treat Options Oncol; 2020 Jun; 21(8):64. PubMed ID: 32601742
[TBL] [Abstract][Full Text] [Related]
13. The Role of Immunotherapy in Extensive Stage Small-Cell Lung Cancer: A Review of the Literature.
Tsiouprou I; Zaharias A; Spyratos D
Can Respir J; 2019; 2019():6860432. PubMed ID: 31781314
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy for small cell lung cancer: established applications and novel approaches.
Scott SC; Hann CL
Clin Adv Hematol Oncol; 2021 Oct; 19(10):654-663. PubMed ID: 34637432
[TBL] [Abstract][Full Text] [Related]
15. The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma.
Mahoney KM; Freeman GJ; McDermott DF
Clin Ther; 2015 Apr; 37(4):764-82. PubMed ID: 25823918
[TBL] [Abstract][Full Text] [Related]
16. Recent Advances and Future Strategies for Immune-Checkpoint Inhibition in Small-Cell Lung Cancer.
Chae YK; Pan A; Davis AA; Mohindra N; Matsangou M; Villaflor V; Giles F
Clin Lung Cancer; 2017 Mar; 18(2):132-140. PubMed ID: 27520630
[TBL] [Abstract][Full Text] [Related]
17. Potential immune escape mechanisms underlying the distinct clinical outcome of immune checkpoint blockades in small cell lung cancer.
Tian Y; Zhai X; Han A; Zhu H; Yu J
J Hematol Oncol; 2019 Jun; 12(1):67. PubMed ID: 31253167
[TBL] [Abstract][Full Text] [Related]
18. Nivolumab for the treatment of small cell lung cancer.
Simeone E; Grimaldi AM; Festino L; Trojaniello C; Vitale MG; Vanella V; Curvietto M; Ascierto PA
Expert Rev Respir Med; 2020 Jan; 14(1):5-13. PubMed ID: 31622114
[No Abstract] [Full Text] [Related]
19. Role of Immune Checkpoint Inhibitors in Small Cell Lung Cancer.
Cooper MR; Alrajhi AM; Durand CR
Am J Ther; 2018; 25(3):e349-e356. PubMed ID: 29722737
[TBL] [Abstract][Full Text] [Related]
20. [Immunotherapy in the Treatment of Lung Cancer].
Fiala O; Šorejs O; Pešek M; Fínek J
Klin Onkol; 2017; 30(Supplementum3):22-31. PubMed ID: 29239189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
